Delivery Order 36F79718D0403-15B50526F00000180
- This delivery order awards $22.73M to Daiichi Sankyo, Inc. for the supply of TURALIO (pexidartinib) 125mg capsules in 120-count bottles, with an ultimate completion date of January 31, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, issued under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB) and funded by Federal Medical Center Carswell, a civilian facility within the Department of Veterans Affairs. Daiichi Sankyo will perform the...
- Federal Medical Center Carswell issued a $22,725.09 delivery order to Daiichi Sankyo, Inc. on July 1, 2026, for TURALIO 125mg (120-count) under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB). The order is placed against a blanket purchase agreement established May 22, 2025, between Daiichi Sankyo and the VA National Acquisition Center, effective through May 21, 2026, with four optional one-year renewal periods. The BPA, valued at $80,206.95, authorizes Veterans Integrated Service...
- The Department of Veterans Affairs Federal Medical Center Carswell awarded a $22.7K delivery order to Daiichi Sankyo, Inc. for 120 units of TURALIO 125mg capsules, a specialized pharmaceutical treatment for tenosynovial giant cell tumor, a rare musculoskeletal condition affecting veteran populations. This firm fixed-price delivery order, issued February 1, 2026, with completion scheduled for February 28, 2026, carries no socioeconomic set-aside designation and represents a single order against...
- This delivery order, valued at $22.7K, awards Daiichi Sankyo, Inc. a supply contract for TURALIO (pexidartinib) 125mg in 120-count bottles to support the Federal Medical Center Carswell, a civilian medical facility within the Department of Veterans Affairs system. The award is structured as a firm fixed-price delivery order with no set-aside designation, issued under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB). Performance will be completed by March 31, 2026, with the award date of...
- Daiichi Sankyo, Inc. received a delivery order award from the Federal Medical Center Carswell valued at $22,061.05 for the supply of TURALIO 125mg capsules (120-count) with a completion date of December 31, 2025. The contract is structured as a firm fixed-price delivery order under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB) and was issued without a set-aside designation. The products will be delivered to Basking Ridge, New Jersey. Daiichi Sankyo specializes in pharmaceutical...
- Daiichi Sankyo, Inc. was awarded a $22,061.05 delivery order by the Federal Medical Center Carswell for TURALIO 125mg in a 120-count bottle configuration, with an ultimate completion date of October 31, 2025. This firm fixed-price contract was issued without a set-aside designation under the General Services Administration (GSA) Pharmaceuticals and Drugs Schedule (FSS-61-IB). The award represents a continuation of Daiichi Sankyo's specialized pharmaceutical supply relationship with the federal...
- Daiichi Sankyo, Inc. was awarded a delivery order valued at $48,124.16 by Veterans Integrated Service Network 20 (VISN 20), part of the Department of Veterans Affairs, on January 20, 2025. The contract, which carries a firm fixed-price structure with no set-aside designation, covers the supply of TURALIO (pexidartinib) pharmaceutical products for delivery to a location in Cary, North Carolina, with a completion deadline of September 30, 2025. This delivery order falls under the GSA...
- This is a federal contract award to Daiichi Sankyo, Inc., a pharmaceutical manufacturer, for the supply of TURALIO 125mg capsules. The contract, valued at $208,538.07, is a delivery order contract with a firm fixed price and was awarded by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 20. The contract has an ultimate completion date of September 30, 2026. Daiichi Sankyo, Inc. is the prime contractor, and the contract is not a set-aside. The company...
- On November 7, 2025, the Department of Veterans Affairs, Veterans Integrated Service Network 5, awarded a firm fixed-price delivery order valued at $36,984.28 to Takeda Pharmaceuticals America Inc. for the supply of TAKHZYRO 150 MG, a specialized pharmaceutical treatment for hereditary angioedema. This delivery order represents a child contract under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB) and carries an ultimate completion date of November 13, 2025. The award was made without a...
- This is a firm-fixed-price delivery order awarded by the Department of Veterans Affairs' (VA) Veterans Integrated Service Network 20 to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $27,913.44 order was placed against Takeda's General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs and has an ultimate completion date of August 19, 2024. The order is for the delivery of emergency pharmaceutical products,...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- 36F79718D0403Federal Supply Schedule
- 36F79718D0403-15B50526F00000180Delivery Order
Federal Medical Center Carswell issued a $22,725.09 delivery order to Daiichi Sankyo, Inc. on June 1, 2026, for TURALIO 125mg (pexidartinib), 120-count oral capsules, with ultimate completion by June 30, 2026. The order was placed under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB). Place of performance is Basking Ridge, New Jersey. Daiichi Sankyo supplies this specialized medication—indicated for treatment of tenosynovial giant cell tumor—to VA healthcare facilities within Veterans Integrated Service Networks 20 and 22 through a blanket purchase agreement established May 22, 2025, and effective through May 21, 2026, with four optional one-year renewal periods. The order carries firm fixed-price pricing with no set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.7k | 7/8/26 |